These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30273966)

  • 21. The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling.
    Li Y; Zhang Z; Zhou X; Li L; Liu Q; Wang Z; Bai X; Zhao Y; Shi H; Zhang X; Ye L
    Cancer Lett; 2014 Dec; 355(2):288-96. PubMed ID: 25304384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer.
    Feldker N; Ferrazzi F; Schuhwerk H; Widholz SA; Guenther K; Frisch I; Jakob K; Kleemann J; Riegel D; Bönisch U; Lukassen S; Eccles RL; Schmidl C; Stemmler MP; Brabletz T; Brabletz S
    EMBO J; 2020 Sep; 39(17):e103209. PubMed ID: 32692442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer.
    Zhang J; Zhou C; Jiang H; Liang L; Shi W; Zhang Q; Sun P; Xiang R; Wang Y; Yang S
    Cell Death Dis; 2017 Apr; 8(4):e2732. PubMed ID: 28383555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZEB1 Mediates Fibrosis in Corneal Endothelial Mesenchymal Transition Through SP1 and SP3.
    Lee J; Jung E; Gestoso K; Heur M
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):41. PubMed ID: 32721022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression.
    Hou LK; Yu Y; Xie YG; Wang J; Mao JF; Zhang B; Wang X; Cao XC
    Oncotarget; 2016 May; 7(18):26016-26. PubMed ID: 27036021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells.
    Xu F; You X; Liu F; Shen X; Yao Y; Ye L; Zhang X
    Cancer Lett; 2013 Jun; 333(1):124-32. PubMed ID: 23352642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth.
    Xu FF; Sun HM; Fang RP; Zhang L; Shi H; Wang X; Fu XL; Li XM; Shi XH; Wu Y; Ye K; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2022 Feb; 43(2):429-445. PubMed ID: 33824459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZEB1 stimulates breast cancer growth by up-regulating hTERT expression.
    Yu P; Shen X; Yang W; Zhang Y; Liu C; Huang T
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2505-2511. PubMed ID: 29288666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 31. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.
    Liu F; Zhang W; You X; Liu Y; Li Y; Wang Z; Wang Y; Zhang X; Ye L
    Oncotarget; 2015 Sep; 6(29):27199-213. PubMed ID: 26309161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g.
    Cai X; Wang X; Cao C; Gao Y; Zhang S; Yang Z; Liu Y; Zhang X; Zhang W; Ye L
    Cancer Lett; 2018 Feb; 415():11-19. PubMed ID: 29174803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8.
    Hu N; Zhang J; Cui W; Kong G; Zhang S; Yue L; Bai X; Zhang Z; Zhang W; Zhang X; Ye L
    J Biol Chem; 2011 Apr; 286(15):13714-22. PubMed ID: 21343296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial-Mesenchymal Transition in Breast Cancer.
    Hou P; Li L; Chen F; Chen Y; Liu H; Li J; Bai J; Zheng J
    Cancer Res; 2018 Jan; 78(2):387-398. PubMed ID: 29187406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer.
    Liu L; Tong Q; Liu S; Cui J; Zhang Q; Sun W; Yang S
    PLoS One; 2016; 11(2):e0148774. PubMed ID: 26882471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HSF1 and Sp1 regulate FUT4 gene expression and cell proliferation in breast cancer cells.
    Yang X; Wang J; Liu S; Yan Q
    J Cell Biochem; 2014 Jan; 115(1):168-78. PubMed ID: 23959823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
    Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
    Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM.
    Zhang X; Zhang Z; Zhang Q; Zhang Q; Sun P; Xiang R; Ren G; Yang S
    Cell Death Dis; 2018 Jan; 9(2):57. PubMed ID: 29352223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ZEB1-regulated inflammatory phenotype in breast cancer cells.
    Katsura A; Tamura Y; Hokari S; Harada M; Morikawa M; Sakurai T; Takahashi K; Mizutani A; Nishida J; Yokoyama Y; Morishita Y; Murakami T; Ehata S; Miyazono K; Koinuma D
    Mol Oncol; 2017 Sep; 11(9):1241-1262. PubMed ID: 28618162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3.
    Li L; Gao P; Li Y; Shen Y; Xie J; Sun D; Xue A; Zhao Z; Xu Z; Zhang M; Li B; Jiang J
    Breast Cancer Res Treat; 2014 Oct; 147(3):487-500. PubMed ID: 25193278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.